Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Bone mineral : A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin

Liu, Yang LU ; Nadeem, Aftab LU ; Sebastian, Sujeesh LU orcid ; Olsson, Martin A. LU ; Wai, Sun N. ; Styring, Emelie LU ; Engellau, Jacob LU ; Isaksson, Hanna LU orcid ; Tägil, Magnus LU and Lidgren, Lars LU , et al. (2022) In Materials Today Bio 14.
Abstract

Efficient systemic pharmacological treatment of solid tumors is hampered by inadequate tumor concentration of cytostatics necessitating development of smart local drug delivery systems. To overcome this, we demonstrate that doxorubicin (DOX), a cornerstone drug used for osteosarcoma treatment, shows reversible accretion to hydroxyapatite (HA) of both nano (nHA) and micro (mHA) size. nHA particles functionalized with DOX get engulfed in the lysosome of osteosarcoma cells where the acidic microenvironment causes a disruption of the binding between DOX and HA. The released DOX then accumulates in the mitochondria causing cell starvation, reduced migration and apoptosis. The HA+DOX delivery system was also tested in-vivo on osteosarcoma... (More)

Efficient systemic pharmacological treatment of solid tumors is hampered by inadequate tumor concentration of cytostatics necessitating development of smart local drug delivery systems. To overcome this, we demonstrate that doxorubicin (DOX), a cornerstone drug used for osteosarcoma treatment, shows reversible accretion to hydroxyapatite (HA) of both nano (nHA) and micro (mHA) size. nHA particles functionalized with DOX get engulfed in the lysosome of osteosarcoma cells where the acidic microenvironment causes a disruption of the binding between DOX and HA. The released DOX then accumulates in the mitochondria causing cell starvation, reduced migration and apoptosis. The HA+DOX delivery system was also tested in-vivo on osteosarcoma bearing mice. Locally delivered DOX via the HA particles had a stronger tumor eradication effect compared to the controls as seen by PET-CT and immunohistochemical staining of proliferation and apoptosis markers. These results indicate that in addition to systemic chemotherapy, an adjuvant nHA could be used as a carrier for intracellular delivery of DOX for prevention of tumor recurrence after surgical resection in an osteosarcoma. Furthermore, we demonstrate that nHA particles are pivotal in this approach but a combination of nHA with mHA could increase the safety associated with particulate nanomaterials while maintaining similar therapeutic potential.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Doxorubicin, Drug delivery, Nano and micro hydroxyapatite, Osteosarcoma, Solid tumor
in
Materials Today Bio
volume
14
article number
100227
publisher
Elsevier
external identifiers
  • pmid:35265825
  • scopus:85125537714
ISSN
2590-0064
DOI
10.1016/j.mtbio.2022.100227
language
English
LU publication?
yes
additional info
Funding Information: Medical Faculty at Lund University and the Lund University Bioimaging Center (LBIC) are thanked for the infrastructure support. We also acknowledge the Biochemical Imaging Center at Umeå University and the National Microscopy Infrastructure, NMI (VR-RFI 2019–00217) for providing assistance with microscopy. Swedish Research Council (Vetenskapsrådet, Grant number: 2021-03447), Berta Kamprad foundation (Grant number: FBKS-2020-23-(269)), Maggie Stephens foundation (Grant number: 20202004), China Scholarship Council (grant number: 201806940015 ), and Cancerfonden (Grant number: 20 0711 PjF) are thanked for the financial support. Funding Information: Medical Faculty at Lund University and the Lund University Bioimaging Center (LBIC) are thanked for the infrastructure support. We also acknowledge the Biochemical Imaging Center at Ume? University and the National Microscopy Infrastructure, NMI (VR-RFI 2019?00217) for providing assistance with microscopy. Swedish Research Council (Vetenskapsr?det, Grant number: 2021-03447), Berta Kamprad foundation (Grant number: FBKS-2020-23-(269)), Maggie Stephens foundation (Grant number: 20202004), China Scholarship Council (grant number: 201806940015), and Cancerfonden (Grant number: 20 0711 PjF) are thanked for the financial support. Publisher Copyright: © 2022
id
2d72f71c-fbf9-47e7-a167-90ba34812721
date added to LUP
2022-04-04 13:09:31
date last changed
2024-04-07 07:22:34
@article{2d72f71c-fbf9-47e7-a167-90ba34812721,
  abstract     = {{<p>Efficient systemic pharmacological treatment of solid tumors is hampered by inadequate tumor concentration of cytostatics necessitating development of smart local drug delivery systems. To overcome this, we demonstrate that doxorubicin (DOX), a cornerstone drug used for osteosarcoma treatment, shows reversible accretion to hydroxyapatite (HA) of both nano (nHA) and micro (mHA) size. nHA particles functionalized with DOX get engulfed in the lysosome of osteosarcoma cells where the acidic microenvironment causes a disruption of the binding between DOX and HA. The released DOX then accumulates in the mitochondria causing cell starvation, reduced migration and apoptosis. The HA+DOX delivery system was also tested in-vivo on osteosarcoma bearing mice. Locally delivered DOX via the HA particles had a stronger tumor eradication effect compared to the controls as seen by PET-CT and immunohistochemical staining of proliferation and apoptosis markers. These results indicate that in addition to systemic chemotherapy, an adjuvant nHA could be used as a carrier for intracellular delivery of DOX for prevention of tumor recurrence after surgical resection in an osteosarcoma. Furthermore, we demonstrate that nHA particles are pivotal in this approach but a combination of nHA with mHA could increase the safety associated with particulate nanomaterials while maintaining similar therapeutic potential.</p>}},
  author       = {{Liu, Yang and Nadeem, Aftab and Sebastian, Sujeesh and Olsson, Martin A. and Wai, Sun N. and Styring, Emelie and Engellau, Jacob and Isaksson, Hanna and Tägil, Magnus and Lidgren, Lars and Raina, Deepak Bushan}},
  issn         = {{2590-0064}},
  keywords     = {{Doxorubicin; Drug delivery; Nano and micro hydroxyapatite; Osteosarcoma; Solid tumor}},
  language     = {{eng}},
  publisher    = {{Elsevier}},
  series       = {{Materials Today Bio}},
  title        = {{Bone mineral : A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin}},
  url          = {{http://dx.doi.org/10.1016/j.mtbio.2022.100227}},
  doi          = {{10.1016/j.mtbio.2022.100227}},
  volume       = {{14}},
  year         = {{2022}},
}